Cutting through the noise in Precision Diagnostics: How CGP labs can better communicate & engage customers across the full offering
Precision diagnostics is at the heart of cancer care, but increasing complexity means innovations can get lost in the noise. Clinicians, under time pressure, often struggle to distinguish between tests and rely on familiarity, habit, and brand trust when making decisions.
In this 30-minute webcast, our Precision Medicine and Diagnostics experts Vanessa Slade, Research Director and Parisa Valadan, Associate Director, explore why true differentiation is often overlooked in real-world practice, and what diagnostic companies can do to ensure their tests and portfolios are clearly understood, valued and adopted. Drawing on our extensive research with clinicians and behavioral science expertise, we uncover how to cut through the complexity and turn innovation into impact.
Key takeaways:
Understand the challenge: What prevents HCPs from successfully navigating the complexity of the precision diagnostics landscape
Learn what really drives clinician behaviour: Understand how tests are really chosen in real-world practice
Discover the opportunity: How to turn differentiation into adoption
Complete the form below to watch the webcast:
Privacy Note: At Purdie Pascoe, we occasionally share the latest MedTech news and insights that we believe may be of interest to you. We will only contact you about topics relevant to your preferences. Your privacy is important to us — you can unsubscribe from our communications at any time. For more information, please see our Privacy Policy.